navitoclax,ruxolitinib
abbvie,novartis,incyte
['refine study', '#myelof', 'ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', 'navitoclax', 'abbvie']
#abbvie announced the phase 2 refine study, demonstrating the efficacy of #navitoclax and #ruxolitinib in #myelofibrosis naive patients. #news #media #pharma #pharmaceutical #ash22 #ash2022 #conferences
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma